$10,000 in Vertex Pharmaceuticals Incorporated: 10-Year Growth Investment Calculator – Total Gain & ROI

Investment Scenario

Vertex Pharmaceuticals Incorporated share price on Jan 1, 2016  

Share Price          : $90.75
Total Share Bought   : 110 shares
Invested Amount      : $9982.50

In 2016, an investor has $10,000 and wants to invest in Vertex Pharmaceuticals Incorporated (VRTX). At that time, the stock price of Vertex Pharmaceuticals Incorporated is $90.75 per share, allowing the investor to purchase 110 shares for a total of $9982.50. This leaves the investor with $17.50 remaining from the initial $10,000.
Instead of chasing short-term gains, the investor adopted a long-term approach—holding the shares for 10 years without selling. Over time, the value of the investment grew not only through stock price appreciation but also through the accumulation of dividend payouts.

Vertex Pharmaceuticals Incorporated share price on Apr 7, 2026 

Share Price       : $431.86
Total Share       : 110 shares (including stock splits, if any) 
Portfolio Value   : $47,504.60

As of Apr 7, 2026, the $9,982.50 investment in NASDAQ:VRTX would be worth approximately $47,504.60 , thanks to stock splits, price appreciation, and consistent dividend payouts. This reflects a total Gain from stocks of $37,522.10, a return on investment (ROI) of 375.88%, and an annualized compounded growth rate (CAGR) of around 16.88%. This highlights the power of long-term investing and shows how a disciplined, patient approach—paired with investing in a fundamentally strong company like Vertex Pharmaceuticals Incorporated (VRTX)—can lead to significant wealth creation over time.

Wealth grew over time through a mix of dividend income and stock price appreciation. Dividends added to capital, while stock splits increased the number of shares held. Even without reinvesting dividends, the portfolio expanded steadily. As years passed, compounding took effect — turning small gains into larger ones. Holding the stock long-term allowed capital to grow naturally. This shows how patience, steady returns, and the power of compounding can help build lasting wealth from a single investment.

Vertex Pharmaceuticals Incorporated Investment Summary (2016–2026)

   
 
 By Apr 7, 2026, the share price increased to $431.86.
 This resulted in a significant appreciation in the value of the investment.
 

 

This performance reflects a Compound Annual Growth Rate (CAGR) of Vertex Pharmaceuticals Incorporated stock, approximately 16.88% 
 — a strong return over the period.

Yearly Breakdown

VRTX 10 years Investment Performance Overview

Vertex Pharmaceuticals Incorporated (Ticker: VRTX) is a 0.110T (Large-Cap) Biotechnology company in the Healthcare sector, listed on the NASDAQ. With a market capitalization of $0.110T (Large-Cap), a PE ratio of 28.17, and an EPS of 15.33, VRTX remains one of American’s most stable and well-established companies.

If we have a look at VRTX's stock performance in last one year, it has traded between a 52-week low of $362.50 and a high of $510.77 per share.

If you had invested $9,982.50 in Vertex Pharmaceuticals Incorporated (VRTX) 10 years ago, your portfolio would have grown significantly by Apr 7, 2026:

• Initial investment: $9,982.50
• Stock Gain: $37.5K
• Total Dividends received: $0.00
• Total return (Stock Gain + Dividends): $37,522.10
• Final Portfolio Value (Initial + Stock Gain + Dividends): $47,504.60

This journey shows that VRTX has not only delivered steady capital appreciation but also rewarded shareholders through consistent dividend payouts, making it a strong long-term wealth compounder in the American stock market.